Updates in Breast Cancer from San Antonio
SABCS 2019 Highlights: Tucatinib + Trastuzumab + Capecitabine May Become the New SoC in HER2+ Metastatic Breast Cancer
By
Updates in Breast Cancer from San Antonio
FEATURING
Elias Obeid
By
Updates in Breast Cancer from San Antonio
FEATURING
Elias Obeid
Login to view comments.
Click here to Login
Videos